Pharmafile Logo
Pharmafocus logo
Advanced Search

MS

Showing 15 posts of 92 posts found.

NICE image

NICE wants more Lemtrada data

December 6, 2013
Sales and Marketing Lemtrada, MS, NICE, Sanofi

NICE has said there are ‘still questions to be answered’ over Sanofi’s submission of its multiple sclerosis drug Lemtrada and …

News
Genzyme image

‘Fatal’ safety concerns throw doubt on Lemtrada

November 11, 2013
Research and Development, Sales and Marketing FDA, Genzyme, Lemtrada, MS, Sanofi

An FDA committee has dashed hopes of an approval for Sanofi’s multiple sclerosis drug after saying its benefits may not …

News
nice_sign

NICE: we need more Aubagio data

September 18, 2013
Sales and Marketing Aubagio, Genzyme, MS, NICE, Sanofi

News
sanofi_chris_viehbacher

Sanofi’s Lemtrada given European go ahead

September 18, 2013
Research and Development, Sales and Marketing Aubagio, Lemtrada, MS, Sanofi, gilenya

News
GSK image

GSK fires head of China research over data fraud

June 11, 2013
Research and Development China, GSK, Jingwu Zang, MS, autoimmune

GlaxoSmithKline has dismissed its vice president of research in China in connection with ‘misrepresentation’ of research data.Jingwu Zang had been senior …

News

Novartis works in MS switch

June 11, 2013
Research and Development, Sales and Marketing MS, Novartis, gilenya

Novartis’ oral MS drug Gilenya has been found to help multiple sclerosis (MS) patients who switch to it after taking …

News
MS Society web image

Charity: MS treatment is ‘lottery’

May 1, 2013
Sales and Marketing MS, lottery, society

Multiple sclerosis care in the UK is a ‘lottery’ according to research by the MS Society. The charity says that …

News
biogen idec image

Multiple sclerosis rivals gain EU approval

March 27, 2013
Research and Development, Sales and Marketing Biogen IDEC, Genzyme, MS

Rival MS treatments from Biogen Idec and Genzyme have both received European approval. The CHMP has recommended marketing authorisation for …

News
Tysabri image

Biogen and Elan file for Tysabri first line use in MS

January 18, 2013
Sales and Marketing Biogen IDEC, EMA, Elan, FDA, MS, Tsyabri, gilenya

Biogen Idec and Elan have applied to the FDA and EMA to expand Tysabri’s use in patients with relapsing forms …

News

Sanofi criticised for multiple sclerosis manoeuvres

November 2, 2012
Sales and Marketing Cancer, Lemtrada, MS, Sanofi

Sanofi is facing a backlash as it prepares its new MS treatment for the market. Lemtrada (alemtuzumab) has produced very …

News
Gilenya image

Novartis’ MS drug improves outcomes

October 15, 2012
Sales and Marketing MS, Novartis, gilenya

Novartis’ multiple sclerosis (MS) drug Gilenya has demonstrated what the manufacturer calls ‘significant’ benefits for patients if used early. Results …

News

Genzyme ‘confident’ of FDA nod for MS drug

August 29, 2012
Sales and Marketing Genzyme, Lemtrada, MS, multiple sclerosis

Genzyme insists it is on course to resubmit an existing oncology drug for the treatment of relapsing multiple sclerosis (RMS), …

News

Sanofi submits key MS pill for approval

June 12, 2012
Research and Development, Sales and Marketing Bayer, EMA, FDA, Genzyme, Lemtrada, MS, Sanofi

Sanofi has submitted its multiple sclerosis pill Lemtrada for regulatory reviews in the US and Europe. Lemtrada (alemtuzumab), originally developed …

News

Merck KGaA swings axe over Serono operations

April 25, 2012
Manufacturing and Production, Research and Development, Sales and Marketing Cladribine, MS, Merck KGaA, Switzerland, job cuts

Merck KGaA will cut around 500 jobs from its pharmaceutical unit in Switzerland, the firm has announced.  The company said …

News
Gilenya picture

NICE U-turn sees Gilenya MS pill recommended

March 16, 2012
Sales and Marketing MS, NICE, UK, fingolimod, gilenya

NICE has changed its mind on Novartis’ multiple sclerosis pill Gilenya, and is now recommending the drug in a subgroup …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025